Cargando…

CINV: still troubling patients after all these years

Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects experienced by patients with cancer. The precise physiologic mechanisms responsible for acute and delayed CINV continue to be elucidated and have provided an opportunity to develop antiemetic therapies targeting t...

Descripción completa

Detalles Bibliográficos
Autor principal:	Aapro, Matti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876280/ https://www.ncbi.nlm.nih.gov/pubmed/29556808 http://dx.doi.org/10.1007/s00520-018-4131-3

Ejemplares similares

Bringing it all together in the treatment of CINV: application of current knowledge into routine clinical practice
por: Warr, David
Publicado: (2018)

Guidelines versus individualized care for the management of CINV
por: Clemons, Mark
Publicado: (2018)

Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
por: Baron-Hay, Sally, et al.
Publicado: (2019)

Oncologist perspectives on chemotherapy‐induced nausea and vomiting (CINV) management and outcomes: A quantitative market research‐based survey
por: Aapro, Matti, et al.
Publicado: (2018)

Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles
por: Navari, Rudolph, et al.
Publicado: (2022)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—concluding thoughts
por: Aapro, Matti
Publicado: (2018)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
por: Aapro, Matti
Publicado: (2018)

Yost Still Troubled By Upside-Down Labels
Publicado: (2009)

Still programming after all these years
por: Metcalf, M
Publicado: (1992)

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy
por: Schwartzberg, Lee, et al.
Publicado: (2019)

Helping patients discuss CINV management: development of a Patient Charter
por: Young, Annie, et al.
Publicado: (2013)

The unfolded protein response in glioblastomas: targetable or trouble?
por: Graner, Michael W
Publicado: (2015)

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
por: Jin, Yilan, et al.
Publicado: (2021)

The emerging role of olanzapine in paediatric CINV control: A review
por: Barušić, Anabella Karla
Publicado: (2022)

Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?
por: D’Souza, Anita, et al.
Publicado: (2020)

Drug exposure: still relevant after all these years
por: Gerber, David E., et al.
Publicado: (2021)

Dopaminergic treatment of patients with acromegaly: still kicking after all these years
Publicado: (2022)

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron
por: Aapro, Matti, et al.
Publicado: (2016)

Doctors and Drug Companies: Still Cozy after All These Years
por: Henry, David
Publicado: (2010)

Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)
por: Rashad, Noha, et al.
Publicado: (2017)

The Clinical Observation of Acupuncture Combined With Antiemetic Drugs in the Prevention and Treatment of CINV in Breast Cancer Patients
por: Kong, Fanming, et al.
Publicado: (2022)

Despite costs, troubles, scientists still seek 'a tiny piece of Genesis'
Publicado: (2009)

After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
por: Zhang, L, et al.
Publicado: (2018)

Erratum: The clinical observation of acupuncture combined with antiemetic drugs in the prevention and treatment of CINV in breast cancer patients
Publicado: (2022)

Changing the landscape of European School of Oncology–European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic
por: Pavlidis, Nicholas, et al.
Publicado: (2022)

Insulin’s Role in Diabetes Management: After 90 Years, Still Considered the Essential “Black Dress”
por: Cefalu, William T., et al.
Publicado: (2015)

Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis
por: Schwartzberg, Lee, et al.
Publicado: (2023)

Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses
por: Clark-Snow, Rebecca, et al.
Publicado: (2017)

Respiratory Troubles after an Æsthetics
Publicado: (1902)

Lung Troubles after Anæsthetics
Publicado: (1908)

What have we learnt from the COVID-19 epidemic? Considerations of a troubled editor after two troubled years
por: Piccoli, Giorgina Barbara
Publicado: (2022)

The Clinical Concept of Opioid Addiction Since 1877: Still Wanting After All These Years
por: Schütz, Christian G., et al.
Publicado: (2018)

Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)
por: Lorusso, Vito, et al.
Publicado: (2020)

The tenth Janet Doe Lecture, a forty-year perspective: still relevant after all these years
por: Peay, Wayne J., et al.
Publicado: (2020)

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
por: Gao, Ai, et al.
Publicado: (2023)

In Trouble
Publicado: (1893)

Trouble
por: Chandler, J. B.
Publicado: (1882)

Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study
por: Kimura, Hiroaki, et al.
Publicado: (2015)

The Troubles of the Masseuses
Publicado: (1899)

Cannot write session to /tmp/vufind_sessions/sess_52a6agflqq170r7r73snpl667h